Table 2.
Description of studies on UGIC and aspirin use published from 1990 to 2001.
| Study | Design | Period | Location | Exposure assessment | Exposure window | Outcome |
|---|---|---|---|---|---|---|
| Laporte et al. [43] | Case-control | 87–88 | Spain | Interview | Last week | Hospitalization for gastric or duodenal bleeding |
| Holvoet et al. [44] | Case-control | 87–89 | Belgium | Interview | Last week | Hospitalization for upper GI tract bleeding |
| Nobili et al. [38] | Case-control | 87–88 | Italy | Interview | Last week | Hospitalization for upper GI tract bleeding+ |
| Keating [45] | Case-control | 87–91 | New Zealand | Records | Index day | Hospitalization for upper GI tract bleeding or perforation |
| Henry et al. [46] | Case-control | 85–89 | Australia | Interview | Last week | Hospitalization for upper GI tract bleeding or perforation |
| Savage et al. [47] | Case-control | 86–90 | New Zealand | Interview | Last week | Hospitalization for gastric or duodenal bleeding or perforation |
| Weil et al. [48] | Case-control | 87–91 | UK | Interview | Last month | Hospitalization for gastric or duodenal bleeding |
| Hallas et al. [49] | Cohort | 91–92 | Denmark | Records | Prescription coverage | Hospitalization for gastric or duodenal bleeding |
| Kelly et al. [51] | Case-control | 87–94 | US | Interview | Last week | Hospitalization for gastric or duodenal bleeding |
| Matikainen et al. [52] | Case-control | 92–93 | Finland | Interview | Last week | Hospitalization for upper GI tract bleeding |
| Pérez Gutthann et al. [54] | Nested Case-control | 82–86 | Canada | Records | Prescription last month | Hospitalization for gastric or duodenal bleeding or perforation |
| McMahon et al. [52] | Cohort | 89–92 | UK | Records | Prescription coverage | Hospitalization for upper GI tract bleeding or perforation |
| Wilcox et al. [53] | Case-control | 91–93 | US | Interview | Last week | Hospitalization for upper GI tract bleeding |
| García Rodríguez et al. [55] | Nested Case-control | 91–95 | Italy | Records | Prescription coverage | Hospitalization for gastric or duodenal bleeding or perforation |
| Lanas et al. [56] | Case-control | 95–98 | Spain | Interview | Last week | Hospitalization for upper GI tract bleeding |
| Sorensen et al. [57] | Cohort | 91–95 | Denmark | Records | Prescription coverage | Hospitalization for upper GI tract bleeding |
| De Abajo et al. [58] | Nested Case-control | 93–98 | UK | Records | Last month | Hospitalization for gastric or duodenal bleeding or perforation |